Abstract
It is well known that the principal biomolecules involved in Alzheimer’s disease (AD) are acetylcholinesterase (AChE), acetylcholine (ACh) and the amyloid beta peptide of 42 amino acid residues (Aβ42). ACh plays an important role in human memory and learning, but it is susceptible to hydrolysis by AChE, while the aggregation of Aβ42 forms oligomers and fibrils, which form senile plaques in the brain. The Aβ42 oligomers are able to produce hydrogen peroxide (H2O2), which reacts with metals (Fe2+, Cu2+, Cr3+, Zn2+, and Cd2+) present at high concentrations in the brain of AD patients, generating the hydroxyl radical (·OH) via Fenton (FR) and Fenton-like (FLR) reactions. This mechanism generates high levels of free radicals and, hence, oxidative stress, which has been correlated with the generation and progression of AD. Therefore, we have studied in vitro how AChE catalytic activity and ACh levels are affected by the presence of metals (Fe3+, Cu2+, Cr3+, Zn2+, and Cd2+), H2O2 (without Aβ42), and ·OH radicals produced from FR and FLR. The results showed that the H2O2 and the metals do not modify the AChE catalytic activity, but the ·OH radical causes a decrease in it. On the other hand, metals, H2O2 and ·OH radicals, increase the ACh hydrolysis. This finding suggests that when H2O2, the metals and the ·OH radicals are present, both, the AChE catalytic activity and ACh levels diminish. Furthermore, in the future it may be interesting to study whether these effects are observed when H2O2 is produced directly from Aβ42.
Similar content being viewed by others
References
Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM (2007) Forecasting the global burden of Alzheimer’s disease. Alzheimers Dement 3:186–191
Talesa VN (2001) Acetylcholinesterase in Alzheimer’s disease. Mech Ageing Dev 122:1961–1969
Lanctôt KL, Herrmann N, Yau KK, Khan LR, Liu BA, LouLou MM, Einarson TR (2003) Efficacy and safety of cholinesterase inhibitors in Alzheimer’s disease: a meta-analysis. CMAJ 169:557–564
Inestrosa NC, Urra S, Colombres M (2004) Acetylcholinesterase (AChE)–amyloid-beta-peptide complexes in Alzheimer’s disease. The Wnt signaling pathway. Curr Alzheimer Res 1:249–254
Akatsu H, Hori A, Yamamoto T, Yoshida M, Mimuro M, Hashizume Y, Tooyama I, Yezdimer EM (2012) Transition metal abnormalities in progressive dementias. Biometals 25:337–350
Hureau Ch (2012) Coordination of redox active metal ions to the amyloid precursor protein and to amyloid-beta peptides involved in Alzheimer disease. Part 1: An overview. Coord Chem Rev 256:2164–2174
Panayi AE, Spyrou NM, Iversen BS, White MA, Part P (2002) Determination of cadmium and zinc in Alzheimer’s brain tissue using inductively coupled plasma mass spectrometry. J Neurol Sci 195:1–10
El-Yazigi A, Martin CR, Siqueira EB (1988) Concentrations of chromium, cesium, and tin in cerebrospinal fluid of patients with brain neoplasms, leukemia or other noncerebral malignancies, and neurological diseases. Clin Chem 34:1084–1086
Pretto A, Loro VL, Morsch VM, Moraes BS, Menezes Ch, Clasen B, Hoehne L, Dressler V (2010) Acetylcholinesterase activity, lipid peroxidation, and bioaccumulation in silver catfish (Rhamdia quelen) exposed to cadmium. Arch Environ Contam Toxicol 58:1008–1014
Sant’Anna MC, Soares V de M, Seibt KJ, Ghisleni G, Rico EP, Rosemberg DB, de Oliveira JR, Schröder N, Bonan CD, Bogo MR (2011) Iron exposure modifies acetylcholinesterase activity in zebrafish (Danio rerio) tissues: distinct susceptibility of tissues to iron overload. Fish Physiol Biochem 37:573–581
Tabner BJ, Turnbull S, King JE, Benson FE, El-Agnaf OMA, Allsop D (2006) A spectroscopic study of some of the peptidyl radicals formed following hydroxyl radical attack on beta-amyloid and alpha-synuclein. Free Radic Res 40:731–739
Butterfield DA (2003) Amyloid beta-peptide [1-42]-associated free radical-induced oxidative stress and neurodegeneration in Alzheimer’s disease brain: mechanisms and consequences. Cur Med Chem 10:2651–2659
Nadal RC, Rigby SEJ, Viles JH (2008) Amyloid beta-Cu2+ complexes in both monomeric and fibrillar forms do not generate H2O2 catalytically but quench hydroxyl radicals. Biochemistry 47:11653–11664
Butterfield DA, Perluigi M, Sultana R (2006) Oxidative stress in Alzheimer’s disease brain: new insights from redox proteomics. Eur J Pharmacol 545:39–50
Gibbons NCJ, Wood JM, Rokos H, Schallreuter KU (2006) Computer simulation of native epidermal enzyme structures in the presence and absence of hydrogen peroxide (H2O2): potential and pitfalls. J Invest Dermatol 126:2576–2582
Whittemore ER, Loo DT, Watt JA, Cotman CW (1995) A detailed analysis of hydrogen peroxide-induced cell death in primary neuronal culture. Neuroscience 67:921–932
Parthasarathy S, Yoo B, McElheny D, Tay W, Ishii Y (2014) Capturing a reactive state of amyloid aggregates: NMR-based characterization of copper-bound Alzheimer disease amyloid β-fibrils in a redox cycle. J Biol Chem 289:9998–10010
Schallreuter KU, Elwary S (2007) Hydrogen peroxide regulates the cholinergic signal in a concentration dependent manner. Life Sci 80:2221–2226
Molochkina EM, Zorina OM, Fatkullina LD, Goloschapov AN, Burlakova EB (2005) H2O2 modifies membrane structure and activity of acetylcholinesterase. Chem-Biol Interact 157–158:401–404
Schallreuter KU, Elwary SMA, Gibbons NCJ, Rokos H, Wood JM (2004) Activation/deactivation of acetylcholinesterase by H2O2: more evidence for oxidative stress in vitiligo. Biochem Biophys Res Commun 315:502–508
Polyakov NE, Leshina TV, Konovalova TA, Kispert LD (2001) Carotenoids as scavengers of free radicals in a Fenton reaction: antioxidants or pro-oxidants? Free Radic Biol Med 31:398–404
Calderon-Garcidueñas L, Serrano-Sierra A, Torres-Jardón R, Zhu H, Yuan Y, Smith D, Delgado-Chávez R, Cross JV, Medina-Cortina H, Kavanaugh M, Guilarte TR (2013) The impact of environmental metals in young urbanites’ brains. Exp Toxicol Pathol 65:503–511
Sato T, Ando Y, Susuki S, Mikami F, Ikemizu S, Nakamura M, Suhr O, Anraku M, Kai T, Suico MA, Shuto T, Mizuguchi M, Yamagata Y, Kai H (2006) Chromium(III) ion and thyroxine cooperate to stabilize the transthyretin tetramer and suppress in vitro amyloid fibril formation. FEBS Lett 580:491–496
Notarachille G, Arnesano F, Calò V, Meleleo D (2014) Heavy metals toxicity: effect of cadmium ions on amyloid beta protein 1–42. Possible implications for Alzheimer’s disease. Biometals 27:371–388
Bonting SL, Featherstone RM (1956) Ultramicro assay of the cholinesterases. Arch Biochem Biophys 61:89–98
Huang X, Atwood CS, Hartshorn MA, Multhaup G, Goldstein LE, Scarpa RC, Cuajungco MP, Gray DN, Lim J, Moir RD, Tanzi RE, Bush AI (1999) The Abeta peptide of Alzheimer’s disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 38:7609–7616
Moon MY, Kim HJ, Li Y, Kim JG, Jeon YJ, Won HY, Kim JS, Kwon HY, Choi IG, Ro E, Joe EH, Choe M, Kwon HJ, Kim HC, Kim YS, Park JB (2013) Involvement of small GTPase RhoA in the regulation of superoxide production in BV2 cells in response to fibrillar Aβ peptides. Cell Signal 25:1861–1869
Leung E, Guo L, Bu J, Maloof M, El Khoury J, Geula Ch (2011) Microglia activation mediates fibrillar amyloid-β toxicity in the aged primate cortex. Neurobiol Aging 32:387–397
Tabner BJ, El-Agnaf OMA, Turnbull S, German MJ, Paleologou KE, Hayashi Y, Cooper LJ, Fullwood NJ, Allsop D (2005) Hydrogen peroxide is generated during the very early stages of aggregation of the amyloid peptides implicated in Alzheimer disease and familial British dementia. J Biol Chem 280:35789–35792
Multhaup G, Ruppert T, Schlicksupp A, Hesse L, Beher D, Masters CL, Beyreuther K (1997) Reactive oxygen species and Alzheimer’s disease. Biochem Pharmacol 54:533–539
Baruch-Suchodolsky R, Fischer B (2008) Soluble amyloid beta1-28-copper(I)/copper(II)/iron(II) complexes are potent antioxidants in cell-free systems. Biochemistry 47:7796–7806
Vellom DC, Radić Z, Li Y, Pickering NA, Camp S, Taylor P (1993) Amino acid residues controlling acetylcholinesterase and butyrylcholinesterase specificity. Biochemistry 32:12–17
Milton NG (2004) Role of hydrogen peroxide in the aetiology of Alzheimer’s disease: implications for treatment. Drugs Aging 21:81–100
Greenough MA, Camakaris J, Bush AI (2013) Metal dyshomeostasis and oxidative stress in Alzheimer’s disease. Neurochem Int 62:540–555
Ji JA, Zhang B, Cheng W, Wang JY (2009) Methionine, tryptophan, and histidine oxidation in a model protein, PTH: mechanisms and stabilization. J Pharm Sci 98:4485–4500
Wells MA, Bruice TC (1977) Intramolecular catalysis of ester hydrolysis by metal complexed hydroxide ion. Acyl oxygen bond scission in Co2+ and Ni2+ carboxylic acid complexes. J Am Chem Soc 99:5341–5356
Butterworth J, Eley DD, Stone GS (1953) Acetylcholine. 1. Hydrolysis by hydrogen and hydroxyl ion. Biochem J 53:30–34
Cuajungco MP, Fagét KY, Huang X, Tanzi RE, Bush AI (2000) Metal chelation as a potential therapy for Alzheimer’s disease. Ann N Y Acad Sci 920:292–304
Acknowledgments
The authors wish to thank CONACYT (132353; 84119), CYTED: 20140482, ICyTDF (2011/276/279), and COFAA-SIP/IPN (2014/0252/1140/1115/) for their financial support.
Conflict of interest
The authors declare that no having conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Méndez-Garrido, A., Hernández-Rodríguez, M., Zamorano-Ulloa, R. et al. In Vitro Effect of H2O2, Some Transition Metals and Hydroxyl Radical Produced Via Fenton and Fenton-Like Reactions, on the Catalytic Activity of AChE and the Hydrolysis of ACh. Neurochem Res 39, 2093–2104 (2014). https://doi.org/10.1007/s11064-014-1400-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-014-1400-5